Abstract
Research on neutralizing antibodies against the 3 serotypes of poliovirus was carried out on 441 blood specimens drawn from children and young people living in Parma, a town of about 200.000 inhabitants, where the vaccination services were well organized. From June 1983 to June 1984 blood samples were taken from different groups of subjects at different stages of vaccination (before vaccination, and after 1, 2, 3, and 4 doses of trivalent balanced OPV).
In addition, groups of children and young people vaccinated from 2 to more than 14 years earlier were bled. Ten per cent of unvaccinated babies (aged 1–3 months) were lacking in neutralizing antibodies for types 1 and 3 and five per cent for type 2; among children aged 4–5 months vaccinated by one dose of OPV a residual 5% of subjects without antibodies for type 1 was also found.
All subjects who received two, three, or four doses, had antibodies against all serotypes of poliovirus.
As for the number of administered doses, significant differences among GMTs of antibodies were recorded only for type 1, when the group given 3 doses, was compared with the group which received two and one dose, respectively.
At different intervals from completion of vaccination (2–14 years), all groups we examined still had antibodies against all three serotypes.
For poliovirus type 1 antibody, GMTs were not significantly different in the examined groups. For types 2 and 3 significant decreases were observed in the groups vaccinated from 2 to 5 years.
The high levels of immunity observed earlier in Parma were not found throughout the entire territory. Of 69 subjects living in a remote mountain village (65 km from Parma) the prevalence of seronegatives was about 6% for types 1 and 3, 6–9 years after vaccination and about 8% for type 1, 10–13 years after.
Similar content being viewed by others
References
Belian W. (1967): Poliomyelitis antibody statistical survey in the G.D.R. after 6 years of systematical oral inoculation with attenuated virus using poliomyelitis live vaccine type Sabin - Tschumakow. XI Symposium Ass. Europ. Poliomyèlite et Maladies Assoeiées. Rome 9–12 Oct. 1966. Ed. Masson, Paris.
Bey E. and Golombick T. (1984): A comparison of three methods for titration of poliovirus vaccines.- J. Virol. Meth., 9: 123–130.
Biffi M.R., Tagger A., Bruscolini F., Salvaggio L. and Albano A. (1982): Escrezione fecale di poliovirus in soggetti sottoposti a vaccinazione antipoliomielitica.- N. Ann. d'Ig. e Microb., 33: 285–294.
Burke D.S., Gaydos J.C., Hodder A.R. and BancroftH.W. (1979): Seroimmunity to polioviruses in U.S. Army recruits. - J. Inf. Dis., 139: 225–227.
Cellesi C. and Rossolini A. (1984): La vaccinazione antipoliomielitica. - Fed. Med. Chir., 6: 13–16.
Cesario T.C., Jones V., Poland P.D. and Chin T.D.Y. (1969): Persistence of poliovirus neutralizing antibodies four years after immunization with live attenuated vaccine. - Am. J. Epidemiol., 90: 157–161.
Collingham K.E. and Pollock M.T. (1978): Paralytic poliomyelitis in England and Wales 1976–7. - The Lancet, 7: 976–977.
Cood A.A. and White E. (1977): Protection against poliomyelitis. - The Lancet, 11: 1078.
Editorial (1981) : Monitoring of circulation of poliovirus in waste water. - Wkly Epidem. Rec., 56: 105.
Editorial (1981) : Poliomyelitis 1980. Part I. - Wkly Epidem. Rec., 56: 329–333.
Editorial (1983): Poliomyelitis surveillance. - Wkly Epidem. Rec., 58: 271.
Editorial (1983): Poliomyelitis surveillance. - Wkly Epidem. Rec., 58: 292–293.
Editorial (1983): Poliomyelitis in 1982. - Wkly Epidem. Rec., 58: 385–390.
Editorial (1984): Poliomyelitis surveillance. - Wkly Epidem. Rec., 59: 82.
Ferrante P., Barbi M. e Fasan M. (1980): Stato attuale della immunità verso la poliomielite della popolazione di Milano. Risultati preliminari. - Ig. Moderna, 74: 917–925.
Freestone D.S., Kelly A., Ferris R., Simmons R.L.L., Bowker C., Letley E. and Bye C. (1980): Comparison of antibody responses and virus shedding following administration of trivalent oral poliomyelitis vaccines prepared either in monkey kidney or human diploid cell substrates. - J. Hvg. Comb., 84: 17–28.
Furesz J., Armstrong R.E. and Contrera G. (1978): Viral and epidemiological links between poliomyelitis outbreaks in unprotected communities in Canada and the Netherlands. - The Lancet, 11: 1248.
Giuliani G., Frezet D., Paggi G.C. and Varetti G. (1982): Indagini sullo stato immunitario umorale antipoliomielitico della popolazione piemontese a 15 anni dall'introduzione della vaccinazione con vaccino orate di Sabin. - Ann. Sclavo, 24: 5–15.
Grinstein S., Melnick J.L. and Wallis C. (1970): Isolation from sewage and from a stream receiving affluents of sewage treatment plants. - Bull. WHO, 42: 291.
Hinman A.R. (1984): Mass vaccination against polio. - JAMA, 251: 2994–2996.
Horstmann D.M. (1982): Control of poliomyelitis: a continuing paradox, - J. Inf. Dis., 146: 540–551.
Just M. and Ritzel G. (1966): The immune-status of schoolchildren against poliomyelitis six and four years after vaccination with live poliovirus vaccine. XI Simposium Assoc. Europ. Poliomyèlite et Maladies Associées. Rome, 9–12 Oct., 1966. Ed. Masson, Paris.
Kašovà V., Koza J. and Matyšova I. (1981): High and prolonged incidence of poliovirus strains during 1979 in north Bohemia. Isolations from unusual materials. - Zbl. Bakt. Hyg. 1. Abt. Orig. A, 251: 1–14.
Lamb G.A., Plexico K., Glezen W.P. and Chin T.D.Y. (1965): Use of microtechnique for serum neutralization and virus identification. - Publ. Health Rep., 80: 463–466.
Lamy M.E. (1980): Results of poliomyelitis vaccination in Belgium. Excerpta Med., Sect. 17, 34: 576.
Mayer R.T. and Balfour H.H. (1981): Prevalence of poliovirus neutralizing antibodies in young adult women. - JAMA, 246: 1207–1209.
Metselaar D., McDonald K., Gemert W., VanRensM.M. and Muller A. (1977): Poliomyelitis: epidemiology and prophylaxis. 5. Results of a two —and three — dose vaccination experiment. - Bull. WHO, 55: 755–759.
Monaci V., Vitali M.A., Trombetta N., Bellelli E. and Nardi G. (1966): Stato immunitario dopo 1 anno dalla rivaccinazione antipoliomielitica orale con vaccino trivalente attenuato Sabin. - Ann. Sclavo, 8: 244–254.
Monaci V., Yitali M.A., Trombetta N., Bellelli E. and Nardi G. (1967): Status of immunity -one year after antipolio revaccination by trivalent attenuated vaccine (Sabin) in some zones of Northern Italy. XI Symposium Ass. Europ. poliomyèlite et maladies associeés, Rome, 9–12 Oct. 1966. Ed. Masson, Paris.
Monaci V., Nardi G. and Bellelli E. (1971): Stato immunitario della popolazione verso la poliomielite (Nota I). - Ann. Sclavo, 13: 305–32.
Moore M., Katona P.; Kaplan E.J., SchonbergerL.B. and Hatch M.H. (1982): Poliomyelitis in the United States 1969–1981. - J. Inf. Dis., 146: 558–563.
Mortimer P.P. and Cunningham P. (1975): Seroimmunity to poliovirus in children and young women: England 1972–4. - J. Hyg. Camb., 74: 283–287.
Nardi G., Bellelli E., Tanzi M.L., Bracchi U., MonaciV. and Corsello A. (1971): Stato immunitario verso la poliomielite in vari gruppi di popolazione. Nota II. - Ann. Sclavo, 13: 553–566.
Oberhofer T.R., Brown C.G. and Monto S.A. (1975): Seroimmunity to poliomyelitis in an american community. - Am. J. Epidemiol., 101: 333–339.
Rangelova S.M. (1982): Control of poliomyelitis in Bulgaria: experience of two decades. - Progres Med. Virol., 31: 183–211.
Roebuck M. and Chamberlain R. (1982): Prevalence of antibodies to poliovirus in 1978 among subjects aged 0–88 years. - B.M.J., 284: 697–700.
Sabin A.B. (1980): Vaccination against poliomyelitis in economically underveloped countries. - Bull. WHO, 58: 141–157.
Sabin A.B. and Silva E. (1983): Residual paralytic poliomyelitis in a tropical region of Brazil, 1969–1977: prevalence surveys in different age groups as indicators of changing incidence. - Am. J. Epidemiol., 117: 193–200.
Santoro R., Lombardi F., Novello F., Amato C., Ruggeri M.F., Grandolfo H.E., Annesi I., CoriellessaC.M., Timperi F. and Inglese R. (1984): Serum antibodies to poliomyelitis in Italy. - Bull. WHO, 62: 591–595.
Stagni G., Merletti L. and DeRosa F. (1979): Livelli di anticorpi specifici per i virus poliomielitici e grado di protezione immunitaria nella popolazione umbra. - Boll. Ist. Sieroter. Mil., 58: 210–215.
SulliMn E.J. and Rosembaum M.S. (1967): Methods for preparing tissue colture in disposable microplates and their use in virology. - Am. J. Epidemiol., 85: 424–437.
Tanzi M., Bracchi U. and Bellelli E. (1984): Anticorpi neutralizzanti i tre virus poliomielitici in sieri materni e neonatali. - Ig. Moderna, 82: 330–346.
Trivello R., Romano M., Moschen M.E. and Rausa G. (1979): Immunità umorale antipoliomielitica in bambini delle scuole materne a varia distanza di tempo dalla somministrazione del vaccino Sabin.- Ig. Moderna, 72: 536–547.
Trombetta N., Bellelli E., Nardi G., Vitali M.A. Monaci V. (1967): Stato immunitario dopo 2 anni dalla rivaccinazione antipoliomielitica orale con vaccino trivalente Sabin. - Ann. Sclavo, 9: 414–422.
Volpi A., Ragona G., Biondi W., Rocchi G. and Archetti T. (1976): Seroimmunity to polioviruses in an urban population of Italy. - Bull. WHO, 54: 275–278.
Weise H.J. (1980): Poliomyelitis in the GFR (including West Berlin) in 1968–1977. - Excerpta Med., Sect. 17, 34: 162.
Author information
Authors and Affiliations
Additional information
Corresponding author
Rights and permissions
About this article
Cite this article
Bellelli, E., Bracchi, U., Tanzi, M.L. et al. Poliomyelitis immunity status at different intervals from vaccination. Eur J Epidemiol 2, 197–204 (1986). https://doi.org/10.1007/BF00211532
Issue Date:
DOI: https://doi.org/10.1007/BF00211532